ConductScience.org, home

Paper36045346

PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma.

Garces de Los Fayos Alonso I and 39 others. Mol Cancer, 2022. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma. Papers, record 36045346. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36045346

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma.
PubMed
Journal
Mol Cancer
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
1.22
iCite
Revised in PubMed
2025-05-30
PubMed

Authors40

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Garces de Los Fayos Alonso II
2Zujo LL
3Wiest II
4Kodajova PP
5Timelthaler GG
6Edtmayer SS
7Zrimšek MM
8Kollmann SS
9Giordano CC
10Kothmayer MM
11Neubauer HAH A
12Dey SS
13Schlederer MM
14Schmalzbauer BSB S
15Limberger TT
16Probst CC
17Pusch OO
18Högler SS
19Tangermann SS
20Merkel OO

Source PubMed

See all 40 authorsDownload CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lymphoma, Large-Cell, AnaplasticMajor topic
Receptor, Platelet-Derived Growth Factor betaMajor topic
STAT3 Transcription FactorMajor topic
STAT5 Transcription FactorMajor topic
Anaplastic Lymphoma Kinase
Animals
Carcinogenesis
Cell Line, Tumor
Humans
Mice
Phosphorylation
Signal Transduction

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
I 4066Austrian Science Fund FWFAustriaPubMedPubMed
I 4156Austrian Science Fund FWFAustriaPubMedPubMed
I 4154Austrian Science Fund FWFAustriaPubMedPubMed
P 27132Austrian Science Fund FWFAustriaPubMedPubMed
R35 CA210064NCI NIH HHSUnited StatesR35CA210064PubMedNIH RePORTER

Download CSV of grants

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111090048CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.Blood2000https://conductscience.org/library/papers/11090048PubMed
234320169A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells.Blood2021https://conductscience.org/library/papers/34320169PubMed
315659500
Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.
J Clin Oncol2005https://conductscience.org/library/papers/15659500PubMed
415827959Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10.Eur J Immunol2005https://conductscience.org/library/papers/15827959PubMed
529728695Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer.Leukemia2018https://conductscience.org/library/papers/29728695PubMed
631366041The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis.Cancers (Basel)2019https://conductscience.org/library/papers/31366041PubMed
717922009STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression.Nat Med2007https://conductscience.org/library/papers/17922009PubMed
89777954Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.Am J Pathol1998https://conductscience.org/library/papers/9777954PubMed
933310759Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis.Life Sci Alliance2021https://conductscience.org/library/papers/33310759PubMed
1018232729Targeting PDGF signaling in carcinoma-associated fibroblasts controls cervical cancer in mouse model.PLoS Med2008https://conductscience.org/library/papers/18232729PubMed
1131690038STAT5A and STAT5B-Twins with Different Personalities in Hematopoiesis and Leukemia.Cancers (Basel)2019https://conductscience.org/library/papers/31690038PubMed
1222187331Dynamic CpG-DNA methylation of Il10 and Il19 in CD4+ T lymphocytes and macrophages: effects on tissue-specific gene expression.Klin Padiatr2012https://conductscience.org/library/papers/22187331PubMed
1326736010Abrupt Relapse of ALK-Positive Lymphoma after Discontinuation of Crizotinib.N Engl J Med2016https://conductscience.org/library/papers/26736010PubMed
1419088198Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1).Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/19088198PubMed
1531817106JAK2 Inhibition Impairs Proliferation and Sensitises Cervical Cancer Cells to Cisplatin-Induced Cell Death.Cancers (Basel)2019https://conductscience.org/library/papers/31817106PubMed
1630679796Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia.Leukemia2019https://conductscience.org/library/papers/30679796PubMed
1731756496Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial.J Thorac Oncol2020https://conductscience.org/library/papers/31756496PubMed
1829284669MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification.Cancer Discov2018https://conductscience.org/library/papers/29284669PubMed
1933352844The Emerging Therapeutic Landscape of ALK Inhibitors in Non-Small Cell Lung Cancer.Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/33352844PubMed
2017908974Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastases.Clin Cancer Res2007https://conductscience.org/library/papers/17908974PubMed

See all 61 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42881166Ablation of CDK6 and STAT5B rewires T cell developmental dynamics and prevents ALK+ lymphoma formation.Nat Commun2026https://conductscience.org/library/papers/42881166PubMed
41924268IQDMA disrupts STAT5 nuclear transport through CDC42-PAK2 axis collapse in cutaneous T-cell lymphoma.Front Immunol2026https://conductscience.org/library/papers/41924268PubMed
41107802Novel combination therapy with phenformin enhances the effects of lenvatinib in hepatocellular carcinoma via AMPK-mediated PDGFRβ degradation.Cancer Cell Int2025https://conductscience.org/library/papers/41107802PubMed
40591076Mechanistic study of butylphthalide in alleviating cerebral Edema after intracerebral Hemorrhage by regulating miR-7-5p expression.Metab Brain Dis2025https://conductscience.org/library/papers/40591076PubMed
40376194JAK-STAT Signaling in Autoimmunity and Cancer.Immunotargets Ther2025https://conductscience.org/library/papers/40376194PubMed
40364836Role of FHOD1 in tumor cells and tumor immune microenvironment.Front Immunol2025https://conductscience.org/library/papers/40364836PubMed
40175628HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy.Leukemia2025https://conductscience.org/library/papers/40175628PubMed
40073758Anti-Cancer Potential of a new Derivative of Caffeic Acid Phenethyl Ester targeting the Centrosome.Redox Biol2025https://conductscience.org/library/papers/40073758PubMed
40055571ALK in cancer: from function to therapeutic targeting.Nat Rev Cancer2025https://conductscience.org/library/papers/40055571PubMed
38745318PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5A-mediated chromatin accessibility.J Exp Clin Cancer Res2024https://conductscience.org/library/papers/38745318PubMed
38618957Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.J Clin Invest2024https://conductscience.org/library/papers/38618957PubMed
38306597Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs).Blood2024https://conductscience.org/library/papers/38306597PubMed
38172648The regulatory relationship between transcription factor STAT3 and noncoding RNA.Cell Mol Biol Lett2024https://conductscience.org/library/papers/38172648PubMed
37608819Dental Pulp Stem Cell-Derived Exosomes Regulate Anti-Inflammatory and Osteogenesis in Periodontal Ligament Stem Cells and Promote the Repair of Experimental Periodontitis in Rats.Int J Nanomedicine2023https://conductscience.org/library/papers/37608819PubMed
37564202A novel mouse model of heart failure with preserved ejection fraction after chronic kidney disease induced by retinol through JAK/STAT pathway.Int J Biol Sci2023https://conductscience.org/library/papers/37564202PubMed
37173951The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy.Cancers (Basel)2023https://conductscience.org/library/papers/37173951PubMed

Download CSV of cited by

Genes35

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
EPAS12034PubTator's text mininghttps://conductscience.org/library/genes/2034NCBI Gene
EPHB22048PubTator's text mininghttps://conductscience.org/library/genes/2048NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
GZMB3002PubTator's text mininghttps://conductscience.org/library/genes/3002NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL10RA3587PubTator's text mininghttps://conductscience.org/library/genes/3587NCBI Gene
IL10RB3588PubTator's text mininghttps://conductscience.org/library/genes/3588NCBI Gene
IL1929949PubTator's text mininghttps://conductscience.org/library/genes/29949NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
IL2050604PubTator's text mininghttps://conductscience.org/library/genes/50604NCBI Gene
IL2159067PubTator's text mininghttps://conductscience.org/library/genes/59067NCBI Gene
JUN3725PubTator's text mininghttps://conductscience.org/library/genes/3725NCBI Gene
JUNB3726PubTator's text mininghttps://conductscience.org/library/genes/3726NCBI Gene

See all 35 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36045346

GET https://conductscience.org/api/papers/v1/36045346/authors?page=2